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Transplantation of enteric nervous system stem
cells rescues nitric oxide synthase deﬁcient
mouse colon
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Enteric nervous system neuropathy causes a wide range of severe gut motility disorders. Cell
replacement of lost neurons using enteric neural stem cells (ENSC) is a possible therapy for
these life-limiting disorders. Here we show rescue of gut motility after ENSC transplantation
in a mouse model of human enteric neuropathy, the neuronal nitric oxide synthase
(nNOS / ) deﬁcient mouse model, which displays slow transit in the colon. We further
show that transplantation of ENSC into the colon rescues impaired colonic motility with
formation of extensive networks of transplanted cells, including the development of nNOSþ
neurons and subsequent restoration of nitrergic responses. Moreover, post-transplantation
non-cell-autonomous mechanisms restore the numbers of interstitial cells of Cajal that are
reduced in the nNOS / colon. These results provide the ﬁrst direct evidence that ENSC
transplantation can modulate the enteric neuromuscular syncytium to restore function, at the
organ level, in a dysmotile gastrointestinal disease model.
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europathological loss within the enteric nervous system
(ENS) has been implicated in a wide range of severe gut
motility disorders, such as achalasia1–3, gastroparesis4,5,
slow transit constipation6–8 and Hirschsprung’s disease
(aganglionic megacolon)9,10, as well as being associated with a
number of central nervous system disorders11–13. Potential
replacement of lost neurons using stem cell replacement is an
attractive therapy for such life-limiting disorders. Enteric neural
stem cells (ENSC), which exist in both embryonic and adult gut,
have been suggested as potential cell source for such
treatments14,15. We and others have previously demonstrated
the potential of both mouse16,17 and human18 ENSC to integrate
within wild-type ganglionated mouse colon. Yet a limiting factor
in the advancement of ENSC therapies for human application has
been the failure to demonstrate functional rescue of motility in
pathological disease models. Recent studies have demonstrated
the successful integration of murine and human ENSC within
aganglionic colon both in vivo16,19 and ex vivo20,21; however, the
severity of the gut phenotype and poor survival of homozygote
mice has limited their in vivo use for investigating the potential
functional rescue, at the organ level, of ENSC-based therapies.
Other models of neuronal loss are, therefore, essential to
test the viability of cell-based transplantation techniques
to restore functional deﬁcits resulting from neuropathology.
The loss of neuronal nitric oxide synthase (nNOS) has been
implicated in a range of human enteric neuropathies22, including
oesophageal achalasia23, infantile hypertrophic pyloric stenosis24,
gastroparesis (idiopathic and diabetic)25, colonic dysfunction26
and Hirschsprung’s disease27,28. Notably, nNOS / mice
recapitulate the clinical phenotype of a number of human
diseases displaying both delayed gastric emptying29–31, and slow
transit in the colon32 hence providing an ideal model to establish
if ENSC can restore function after in vivo transplantation.
Here we show rescue of motility, after transplantation of ENSC,
within the nNOS / mouse colon. We further demonstrate
robust restoration of nitrergic responses coincident with the
development of nNOSþ neurons in an nNOS-deﬁcient
microenvironment. In addition, we show concurrent rescue
of interstitial cells of Cajal (ICC) within the nNOS / colon
after ENSC transplantation. Thus, we propose that ENSC
can modulate the neuromuscular syncytium via both
cell-autonomous and non-cell-autonomous mechanisms to
restore function, at the organ level, and ultimately rescue motility.
Results
Transplanted ENSC extensively integrate in nNOS / colon.
To isolate ENSC, we used donor Wnt1cre/þ ;R26RYFP/YFP mice
(P2–P7), in which neural crest cells and their enteric
derivatives express endogenous yellow ﬂuorescent protein (YFP).
This endogenous expression allowed for isolation and fate-map-
ping of labelled donor ENSC. Selected YFPþ cells maintained
expression and formed characteristic neurospheres within 1
month in culture (Supplementary Fig. 1). To assess the compo-
sition of neurospheres, immunohistochemistry and qRT–PCR
were performed to establish the presence of typical ENS cell types.
Such neurospheres were found to express ENS markers such as
the pan-neuronal marker TuJ1 (Supplementary Fig. 1a), the
neural crest progenitor marker SOX10 (Supplementary Fig. 1b)
and the glial marker S100 (Supplementary Fig. 1c). Notably,
in addition to multipotent neural crest progenitors, neuronal
markers, including NOSþ neurons (Supplementary Fig. 1e–g),
were observed within neurospheres in vitro. Hence, we sought
to establish the ability of such neurospheres to colonize and
populate nNOS / colon in vivo. As opposed to wild-type
colon, which contains nNOSþ cell bodies and ﬁbres (Fig. 1a),
nNOS / mice display complete loss of nNOSþ neurons in the
colon (Fig. 1b).
We transplanted three YFPþ neurospheres (B6 104 cells in
total) into the distal colon of nNOS / mice at P14–P17 via
laparotomy. Live imaging analysis, 4 weeks after transplantation,
revealed the presence of extensive anastomosing networks of
transplanted YFPþ cells colonizing, on average, 5.46±0.5mm2
(n¼ 10) of distal colon at the site of transplantation (Fig. 1c).
Subsequent immunohistochemistry revealed more extensive
networks of GFPþ cells (Supplementary Figs 2 and 3). GFPþ
ﬁlamentous networks could be observed extending in both
oral and aboral directions from the site of transplantation
(Supplementary Fig. 2 and Supplementary Movie 1) including
integration within the proximal colon. Post-acquisition mapping
of transplanted cells revealed the largest continuous GFPþ
network extending 10.79mm (Supplementary Fig. 2b). Along
the length of the colon GFPþ cells were found to co-express the
neuronal marker TuJ1 (Fig. 1d–f) and project ﬁbres (Fig. 1d,
arrowheads), which contacted the endogenous neuronal network
at the level of the myenteric plexus. GFPþ cells were also
identiﬁed within endogenous myenteric ganglia (Fig. 1g–i), where
ﬁne GFPþ ﬁbres and varicosities were observed encompassing
and tracing the path of endogenous neuronal ﬁbre tracts (Fig. 1g,
arrowheads). Confocal imaging of the entire colon also revealed
GFPþ cells co-expressing TuJ1 integrated within ganglia along
the length of the colon (Supplementary Fig. 3 and Supplementary
Movie 2) up to a maximum of 42.4mm from the site of
transplantation thus conﬁrming the ability of transplanted cells
to migrate within the tunica muscularis. Transplanted cells
displayed enteric neuronal characteristics including integration
of bipolar (Supplementary Fig. 4a–d) and multipolar GFPþ cells
(Supplementary Fig. 4e,f) phenocopying the morphology of
enteric interneurons and motor neurons, respectively.
Transplanted ENSC regenerate nNOSþ neurons. To determine
if transplanted ENSC have the capacity to develop an NOSþ
phenotype in vivo similar to in vitro cultures, immunohis-
tochemistry and RT–PCR were performed. Within the distal
colon, transplanted YFPþ cells co-expressed both the neuronal
marker TuJ1 and the neuronal nitric oxide synthase marker
nNOS (Fig. 2a–d). nNOSþ neurons were identiﬁed within
ganglia-like structures (Fig. 2c,d, arrowheads) extending multiple
nNOSþ projections (Fig. 2c,d, arrows) within the network of
transplanted cells. The presence of nNOSþ neurons was further
conﬁrmed with PCR analysis demonstrating the speciﬁc expres-
sion of the nNOS transcript within transplanted colon compared
with the complete absence of transcript in non-transplanted
tissues (Fig. 2e).
To assess the proliferative capacity of transplanted cells, BrdU
was applied 24 h post surgery and incorporation was assessed at 4
weeks. Incorporation of BrdU was observed within transplanted
cells co-expressing TuJ1 (Fig. 2f–i, arrows) or nNOS (Fig. 2j–m,
arrows) suggesting that transplanted ENSC have the ability to
proliferate at early post-transplantation stages and subsequently
differentiate to form mature neurons including nNOSþ neurons
within an nNOS-deﬁcient microenvironment.
Restoration of nitrergic responses in the nNOS / colon.
Having demonstrated the ability of ENSC to form nNOSþ
neurons in vivo, we assessed whether this integration could
restore nitrergic responses in the nNOS / distal colon.
On electrical ﬁeld stimulation (EFS), C57BL/6J distal colon
displayed large EFS-induced relaxations of  1.98±0.15 g s;
n¼ 5 (Fig. 3a,e). By contrast loss of nNOS within nNOS /
mice resulted in signiﬁcant loss of this relaxatory response
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( 0.31±0.08 g s; n¼ 5, Po0.0001, Student’s t-test; Fig. 3b,e).
Sham-operated nNOS / distal colon displayed similarly
abrogated EFS-induced responses ( 0.296±0.05 g s; n¼ 5;
Fig. 3c,e) to control nNOS / distal colon (P¼ 0.8376, Student’s
t-test). Interestingly, after ENSC transplantation there were
statistically signiﬁcant differences in mean values between control
nNOS / , sham-operated and transplanted nNOS / groups
as determined by one-way analysis of variance (ANOVA)
(F(2,12)¼ 20.78, Pr0.001) with transplanted nNOS / distal
colon displaying signiﬁcant increases in EFS-induced relaxation
( 1.13±0.16 g s; n¼ 5; Fig. 3d,e) compared to sham-operated
nNOS / mice (P¼ 0.0012, Student’s t-test). There was,
however, a statistical difference between C57BL/6J distal colon
and that of transplanted nNOS / mice (P¼ 0.0034, Student’s
t-test). On EFS, C57BL/6J distal colon also displayed post-
stimulation rebound contractions with a mean amplitude
of 0.326±0.04 g; n¼ 5 (Fig. 3a,f). Similarly, nNOS / mice
displayed these post-stimulation rebound contractions
(0.22±0.06 g; n¼ 5, P¼ 0.1586, Student’s t-test; Fig. 3b,f). Sham-
operated nNOS / distal colon displayed similar responses
(0.315±0.04 g; n¼ 5; Fig. 3c,f) to nNOS / mice (P¼ 0.2083,
Student’s t-test). Interestingly, after ENSC transplantation, there
were statistically signiﬁcant differences in mean values between
control nNOS / , sham-operated and transplanted nNOS /
groups by one-way ANOVA (F(2,12)¼ 7.61, P¼ 0.007) with
transplanted nNOS / distal colon displaying signiﬁcant
increases in rebound contraction amplitude (0.708±0.15 g; n¼ 5;
Fig. 3d,f) compared to sham-operated nNOS / mice
(P¼ 0.032, Student’s t-test) and C57BL/6J distal colon
(P¼ 0.0354, Student’s t-test).
To establish if the restored relaxatory response was due to the
presence of transplanted nNOSþ neurons, EFS-induced
responses observed in non-adrenergic non-cholinergic conditions
were analysed in the presence and absence of the nitric oxide
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Figure 1 | Transplanted ENSC extensively colonize and integrate within the nNOS / mouse colon. (a) Representative image of NADPH diaphorase
staining in wild-type C57BL/6J. nNOSþ cell bodies (arrows), within enteric ganglia, and nNOSþ ﬁbres (arrowheads) are indicated. (b) Representative
image of NADPH diaphorase staining of nNOS / mouse colon demonstrating loss of nitrergic innervation with the absence of NADPH diaphorase
staining. (c) Representative stereoscopic montage image of transplanted YFPþ cells within the nNOS / distal colon at 4 weeks. Transplanted cells form
large anastomosing networks comprising cell bodies (arrows) and ﬁbres (arrowheads), including ganglia-like structures (asterisk). Scale bar, 500mm.
(d) Example confocal image demonstrating co-expression of the neuronal marker TuJ1 within YFPþ -transplanted cells. YFPþ cell bodies (arrow) project
ﬁbres (arrowheads) towards the endogenous neuronal network at the level of the myenteric plexus. (e,f) Individual channels showing GFP and TuJ1 staining
from d. (g) Representative confocal image demonstrating the presence and integration of transplanted cells within endogenous ganglia. At the level of the
myenteric plexus, ﬁne GFPþ ﬁbres and varicosities encompass and trace endogenous neuronal ﬁbre tracts (arrowheads). GFPþ cells were also identiﬁed
within ganglia (arrow). (h,i) Individual channels taken from g showing GFP and TuJ1 staining at the level of the myenteric plexus. Scale bar, 50mm (d–i).
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synthase blocker L-NAME. L-NAME signiﬁcantly reduced this
EFS-induced relaxation ( 0.74±0.17 g s versus  0.12±0.16 g s;
n¼ 4; P¼ 0.0389, Student’s t-test) in transplanted nNOS /
colon (Fig. 3g–i). Taken together, these results indicate that
transplantation of ENSC and development of nNOSþ neurons in
the nNOS / distal colon results in partial restoration of
nitrergic responses.
ENSC transplantation increases basal contractile properties.
Organ bath physiology also revealed large amplitude basal
contractions in transplanted nNOS / distal colonic segments
(Fig. 3d). To investigate these responses, basal contractile
patterns were recorded in both the distal and proximal colonic
segments in control conditions (Krebs solution), and after
the addition of individual neurotransmitter antagonists or
tetrodotoxin (TTX).
Wild-type C57BL/6J distal colon displayed signiﬁcantly larger
amplitude basal contractions (0.10±0.01 g; n¼ 5) compared to
nNOS / mice (0.05±0.01 g; n¼ 5; P¼ 0.0029, Student’s t-test;
Fig. 4a,b,i). The distal colon of sham-operated nNOS / mice
was found to display similar contractions (0.09±0.02 g; n¼ 5;
Fig. 4c,i) to that of control nNOS / mice (P¼ 0.0592, Student’s
t-test). One-way ANOVA analysis suggested that there were
statistically signiﬁcant differences in basal contractile amplitude
(F(2,12)¼ 14.43, P¼ 0.001) between control nNOS / ,
sham-operated and transplanted nNOS / mice with signiﬁcant
increases in the average contractile amplitude in transplanted
nNOS / distal colon (0.30±0.06 g, n¼ 5) compared with
sham-operated nNOS / (P¼ 0.0096, Student’s t-test;
Fig. 4c,d,i). Contractile frequency, however, did not appear to
be affected as determined by one-way ANOVA (F(2,12)¼ 2.96,
P¼ 0.090, Fig. 4j). In addition, these increased basal contractile
properties were not signiﬁcantly affected by addition of individual
 
G
FP
 
a
Tu
J1
b
n
N
O
S
c
M
er
ge
d
20
0 
bp
Bra
in
Sto
m
Co
lon
Bra
in
Sto
m
Co
lon
Bra
in
Sto
m
Co
lon
C57BL/6J nNOS–/– nNOS–/–
transplanted
e
 
G
FP
 
f
Tu
J1
g
BR
D
U
h
M
er
ge
i
 
G
FP
 
j
n
N
O
S
k
BR
D
U
l
M
er
ge
m
Figure 2 | Transplanted ENSC form nNOSþ neurons within the nNOS / distal colon. (a–c) Representative confocal z-stack images demonstrating
individual channels for GFP (a), TuJ1 (b) and nNOS (c) within a transplanted cell network present in the nNOS / distal colon. (d) Merged image of individual
channels shown in (a–c) demonstrating triple labelling of transplanted YFPþ cells (green) co-expressing the neuronal marker TuJ1 (red) and the neuronal nitric
oxide synthase marker nNOS (grey). Individual transplanted nNOSþ neuronal cell bodies (arrowheads) extend multiple nNOSþ projections (arrows) to form
an anastomosing network of transplanted cells. Scale bar, 50mm. (e) Representative PCR gel demonstrating speciﬁc nNOS expression within transplanted
nNOS / colon. (f–m) Example confocal images of BrdU incorporation within transplanted cells 4 weeks after application. Triple labelled transplanted cells
(green, f,j) co-express either TuJ1 (red, g) or nNOS (red, k) having incorporated BrdU (grey, h,l) after administration 24h post surgery. Scale bar, 20mm.
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neural antagonists or TTX (Fig. 4e–h and Supplementary Fig. 6)
suggesting that transplantation of ENSC can lead to potential
changes in underlying myogenic motility patterns.
To establish if ENSC transplantation can alter motility patterns
beyond the transplanted distal colonic region, proximal colonic
segments were investigated for changes in basal contractile
patterns. Similar to the distal colon, wild-type C57BL/6J proximal
colon displayed signiﬁcantly larger amplitude contractions
(0.34±0.04 g; n¼ 3) compared to control nNOS / mice
(0.10±0.02 g; n¼ 3; P¼ 0.0044, Student’s t-test; Supplementary
Fig. 5a,b,i). Contractile amplitude in the proximal colon of sham-
operated nNOS / mice was similar (0.10±0.03 g, n¼ 3;
P¼ 0.9931, Student’s t-test) to that of nNOS / mice
(Supplementary Fig. 5b,c,i). One-way ANOVA analysis suggested
that there were statistically signiﬁcant differences in basal
contractile amplitude (F(2,6)¼ 7.38, P¼ 0.024) between control
nNOS / , sham-operated and transplanted nNOS / group
means with transplanted nNOS / proximal colon displaying
contractile events with signiﬁcantly increased amplitude
(0.32±0.07 g; n¼ 3) compared with sham-operated nNOS /
mice (P¼ 0.0412, Student’s t-test; Supplementary Fig. 5c,d,i).
Contractile frequency, however, did not appear to be affected as
determined by one-way ANOVA (F(2,12)¼ 1.21, P¼ 0.362;
Supplementary Fig. 5j). Thus, we conclude that ENSC transplan-
tation to the distal colon results in changes in colonic motor
patterns at sites distant from the transplanted region. Again,
similar to the distal colon, these increased basal contractions
were not affected by TTX (Supplementary Fig. 5e–h and
Supplementary Fig. 6). The failure of TTX to attenuate these
large amplitude colonic contractions in both the distal and
proximal colon suggests that non-cell-autonomous changes in the
neuromusculature occur post transplant.
Transplantation decreases total intestinal transit time. Previous
studies have identiﬁed motility issues, including slow transit, in
the colon of nNOS / mice. To assess the impact of ENSC
transplantation, including the effect restored nitrergic responses
and increased basal contractile properties would have on
motility, total gastrointestinal (GI) transit time was measured.
Control nNOS / mice displayed signiﬁcantly prolonged transit
time (177±8.15min; n¼ 5) compared to C57BL/6J mice
(117.4±2.64min; n¼ 5; P¼ 0.0001, Student’s t-test; Fig. 5a).
Sham-operated nNOS / mice displayed similar transit time
(185.2±14.08min; n¼ 5) to non-transplanted nNOS /
controls (P¼ 0.63, Student’s t-test). Notably, there were
signiﬁcant differences between control nNOS / , sham-oper-
ated and transplanted nNOS / group means as determined
by one-way ANOVA (F(2,12)¼ 16.02, Po0.0001). Moreover,
total GI transit time in transplanted nNOS / mice was
signiﬁcantly decreased (114.8±3.60min; n¼ 5; P¼ 0.0001,
Student’s t-test) compared with sham-operated nNOS / mice,
reducing transit time towards levels observed in C57BL/6J mice
(P¼ 0.5761, Student’s t-test) suggesting rescue of motility
(Fig. 5a).
Analysis of faecal output revealed a signiﬁcant reduction
in output in nNOS / mice (21.61±3.71mg h 1; n¼ 5)
compared with C57BL/6J mice (35.97±2.63mg h 1; n¼ 5;
P¼ 0.0134, Student’s t-test; Fig. 5b). In addition, sham-operated
nNOS / displayed similar faecal output (24.41±2.41mg h 1;
n¼ 5) to that of nNOS / controls (P¼ 0.544, Student’s t-test).
Interestingly, there were statistically signiﬁcant differences in
faecal output between control nNOS / , sham-operated and
transplanted nNOS / group means as determined by one-way
ANOVA (F(2,12)¼ 11.51, P¼ 0.002) with transplantation of
ENSC resulting in signiﬁcant increases in faecal output in
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Figure 3 | ENSC transplantation restores nitrergic responses in
nNOS / distal colon. (a–d) Representative traces of organ bath
contractility in the presence of NANC demonstrating the response, in distal
colonic segments, to EFS. (a) In response to EFS C57BL/6J distal colon
demonstrates nitrergic relaxation, seen as relaxation below basal tension
(dotted line). (b,c) nNOS / non-transplanted and sham-operated
animals display a loss of this response. (d) Transplanted nNOS / mice
display a partial restoration of the response at 4 weeks post transplantation.
(e,f) Quantiﬁcation of EFS-induced relaxation (area under curve, e) and
rebound contraction (f) in C57BL/6J (blue bars, n¼ 5), nNOS / (red
bars, n¼ 5), sham-operated nNOS / (grey bars, n¼ 5) and transplanted
nNOS / (green bars, n¼ 5) distal colon. ****Pr0.0001, **Pr0.01,
*Pr0.05, by Student’s t-test. (g–i) Representative traces of organ bath
contractility in transplanted nNOS / colon in the absence or presence of
the nitric oxide synthase antagonist L-NAME. (i) Summary data of the
effect of L-NAME on the EFS-induced nitrergic response in transplanted
nNOS / distal colon (n¼4). *Pr0.05 by Student’s t-test. Error bars
represent mean±s.e.m. in all panels.
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transplanted nNOS / mice (44.95±4.77mg h 1; n¼ 5)
compared with sham-operated nNOS / mice (P¼ 0.0049,
Student’s t-test), restoring faecal output to levels comparable to
C57BL/6J mice (P¼ 0.1378, Student’s t-test).
Upper GI transit is not affected by ENSC transplantation. As
nNOS / mice display pan-enteric deﬁcits in nNOS signalling
and have been shown to have delayed gastric emptying, we sought
to assess if transplantation to the distal colon could affect
intestinal transit parameters outside of the colonic region.
Using ﬂuorescent in vivo imaging, liquid stomach emptying at
30min (Fig. 5c,d) was signiﬁcantly delayed in nNOS /
mice (32.9±5.9%, n¼ 3) compared to C57BL/6J mice
(56.4±4.6%; n¼ 3; P¼ 0.0316, Student’s t-test) similar to pre-
viously described studies. Notably, no difference was observed in
liquid stomach emptying between control nNOS / ,
sham-operated and transplanted nNOS / group means as
determined by one-way ANOVA (F(2,6)¼ 1.00, P¼ 0.421;
Fig. 5c,d).
To assess partial intestinal transit, mice were killed 90min after
gavage of a ﬂuorescent dye. Fluorescent imaging was performed
ex vivo and the distance the dye had transited was calculated as a
percentage of total intestinal length (Fig. 5e,f). nNOS / mice
displayed reduced intestinal transit (79.9±2.1%, n¼ 3) compared
to C57BL/6J mice (89.1±1.1%, n¼ 3; P¼ 0.0176, Student’s
t-test). Again, there was no difference between control
nNOS / , sham-operated and transplanted nNOS / transit
distance at 90min as determined by one-way ANOVA
(F(2,6)¼ 0.56, P¼ 0.6). We conclude that as both stomach
emptying and partial intestinal transit time are unaffected by
transplantation, the overall improvement in total intestinal transit
time in transplanted nNOS / mice is due to substantial
increases in colonic transit.
ENSC transplantation restores ICC numbers. We next
sought to ensure that the changes in GI function following
transplantation were not secondary to other phenomena such as
inﬂammation. On initial dissection, and after careful analysis, no
signiﬁcant changes in the gross anatomy of the colon or evidence
of inﬂammatory responses were observed (Supplementary
Fig. 7a). In addition, no inﬂammation was observed on histolo-
gical examination (Supplementary Fig. 7b). Histological analysis
also revealed that there were no differences in either colonic
diameter (P40.05; Supplementary Fig. 7c,e) or muscle thickness
1 µM TTX
C57BL/6J
nNOS–/–
nNOS–/–
sham
nNOS–/–
transplanted
0.5 g
1 min
0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
Co
nt
ra
ct
io
ns
 (m
in–
1 )
NS
NS
Basal contraction
frequency
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
g
***
NS ***
Basal contraction
amplitude
C57BL/6J nNOS–/– nNOS–/– sham nNOS–/– transplanted
a e
b f
c g
d h
i j
Figure 4 | ENSC transplantation alters basal contractile patterns in nNOS / distal colon. (a–d) Representative organ bath contractility traces
demonstrating basal contractile properties of C57BL/6J, nNOS / , sham-operated nNOS / and transplanted nNOS / distal colon in control
conditions. (e–h) Representative organ bath contractility traces demonstrating basal contractile properties of C57BL/6J, nNOS / , sham-operated
nNOS / and transplanted nNOS / distal colon from a–d after the addition of TTX. (i) Quantiﬁcation of basal contractile amplitude in C57BL/6J (blue
bars), nNOS / (red bars), sham-operated nNOS / (grey bars) and transplanted nNOS / (green bars) distal colon. n¼ 5 for each group.
***Pr0.001 by Student’s t-test. (j) Quantiﬁcation of basal contractile frequency in C57BL/6J (blue bars), nNOS / (red bars), sham-operated nNOS /
(grey bars) and transplanted nNOS / (green bars) distal colon. n¼ 5 for each group. Error bars represent mean±s.e.m. in all panels.
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Figure 5 | Analysis of GI transit time and stool production in transplanted nNOS / mice. (a,b) Summary data of total GI transit time (a) measured
after oral gavage of dye, and faecal output (b), 4 weeks after transplantation in C57BL/6J (blue bars), non-transplanted nNOS / (red bars), sham-
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(P40.05; Supplementary Fig. 7d,f) when comparing both
the proximal and distal colon in nNOS / , sham-operated
nNOS / and transplanted nNOS / animals by one-way
ANOVA.
To assess if ENSC transplantation may alter other cells
involved in neuromuscular signalling and excitation–
contraction coupling, the numbers of ICC were quantiﬁed in
both the distal (Fig. 6a–e) and proximal (Fig. 6f and
Supplementary Fig. 8) colon. Notably, ICC were reduced in both
distal (48±5; n¼ 3; Fig. 6e) and proximal (87±5; n¼ 3; Fig. 6f)
nNOS / colonic segments compared to C57BL/6J distal
(78±6; n¼ 3; P¼ 0.0158, Student’s t-test) or proximal colon
(115±8; n¼ 3; P¼ 0.0410, Student’s t-test). No difference was
found between ICC numbers in either the distal (34±3; n¼ 3;
P¼ 0.0743, Student’s t-test) and proximal colon (81±4; n¼ 3;
P¼ 0.4504, Student’s t-test) in sham-operated nNOS /
compared to control nNOS / mice (Fig. 6e,f). By contrast,
one-way ANOVA analysis determined that there were statistically
signiﬁcant differences in ICC numbers in both the distal
(F(2,6)¼ 6.47, P¼ 0.032) and proximal (F(2,6)¼ 26.29,
P¼ 0.001) colon when comparing non-transplanted nNOS / ,
sham-operated nNOS / and transplanted nNOS / mice. Of
interest, increased ICC numbers were observed in transplanted
nNOS / mice both in the distal (77±3; n¼ 3) and proximal
colon (130±11; n¼ 3) compared to sham-operated nNOS /
distal (P¼ 0.0006, Student’s t-test; Fig. 6e) and proximal
(P¼ 0.0135, Student’s t-test; Fig. 6f) colon, respectively. This
increase in ICC numbers associated with ENSC transplantation
suggests indirect modulation of cells that contribute to the
neuromuscular syncytium, alongside the integration of trans-
planted neural crest-derived cells. To further assess this indirect
modulation, we investigated if ENSC express trophic factors that
may inﬂuence ICC development. PCR analysis demonstrated the
expression of the stem cell factor (SCF) ligand within ENSC
neurospheres in vitro (Fig. 6g) providing a possible mechanism by
which transplanted cells could alter ICC development and
maintenance after transplantation.
Discussion
Recent studies have demonstrated the functional integration of
both mouse and human ENSC-derived neurons in wild-type
mouse colon after in vivo transplantation16–18. Functional
analysis in these animals that lack a neuropathological
phenotype is restricted to individual or groups of transplanted
neurons rather than assessment of colonic physiology. We now
report that transplantation of a population of selected enteric
neural crest-derived cells has a clear and positive functional
impact, rescuing motility in a pathophysiological mouse
model that recapitulates the phenotype of several clinically
relevant human disorders. We demonstrate that this rescue is
achieved through both cell-autonomous restoration of nitrergic
responses that were absent, and non-cell-autonomous rescue
of ICC numbers, which were also found to be deﬁcient in the
nNOS / colon.
The ability to form nitrergic neurons is a critical step in the
development of ‘normal’ enteric circuitry and many enteric
disorders would likely beneﬁt from the transplantation and
engraftment of nNOSþ cells. In clearly demonstrating the
potential to restore nNOS neurons after ENSC transplantation,
which to our knowledge is the ﬁrst study to show functional
effects at the organ level, we believe ENSC therapies could impact
widely at the clinical level. Interestingly, transplantation of ENSC
led to restoration of nitrergic responses and increases in
post-stimulation ‘rebound’ contraction. Previous studies have
suggested that this post-stimulation contraction is mediated via
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(a–d) Representative z-stack confocal images of ICC in C57BL/6J,
nNOS / , sham-operated nNOS / and transplanted nNOS / distal
colon. Scale bar, 50mm. (e,f) Quantiﬁcation of ICC numbers in the distal
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Error bars represent mean±s.e.m. in all panels. (g) Representative PCR gel
demonstrating expression of SCF ligand in Wnt1cre/þ ;R26RYFP/YFP-derived
neurospheres (NS). Neurosphere cultures were derived from separate
Wnt1cre/þ ;R26RYFP/YFP intestines (n¼ 3). Autoclaved Milli-Q water (DW)
was used as a non-template negative control.
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nitric oxide33 or through a generalized inhibitory response via
eicosanoids rather than linked to a distinct inhibitory
transmitter34. The ﬁnding that transplantation of ENSC cells
restored nitrergic inhibitory responses and altered post-stimulus
responses suggests adaptation of neuromuscular signalling
mechanisms at multiple levels. Of note, there are differences in
the methodology of our study and that of these earlier studies,
hence further investigation is required to assess the functional
interaction of transplanted ENSC at the cellular level.
Furthermore, the novel ﬁnding that ENSC transplantation
rescues ICC numbers in the nNOS / colon in a non-cell-
autonomous fashion raises interesting questions regarding the
interaction of transplanted ENSC with associated cells within
intestinal tissues. Intestinal excitation–contraction coupling is
extremely complex, with GI smooth muscle receiving inputs
from multiple excitable cells. ICC exist within extensive
networks throughout the intestinal tract35 exhibiting pacemaker
activity36–38 and transducing neural signals to the smooth
muscle39,40. Recent studies show that ICC are innervated by
nitrergic nerves41 and express nitric oxide sensitive guanylate
cyclase in both guinea pig42 and mouse colon43 and
that disruptions in nNOS signalling can result in loss of ICC in
the stomach25,44. The ﬁndings of similar disruptions in ICC
networks, in the present study, along the length of the nNOS /
colon further emphasize the link between NOS signalling and
ICC development. Our previous work has demonstrated that the
selection of ENSC, as in this study, excludes incorporation of
mesenchyme-derived ICC45. Notably, previous studies have
suggested that enteric neurons are the dominant source of SCF,
the natural ligand for c-Kit46, and that 60% of nNOSþ enteric
neurons express SCF47 possibly providing a direct signalling link
between enteric neurons and ICC. The ﬁnding that ENSC-derived
neurospheres express SCF ligand in line with these earlier
reports provides a possible mechanism whereby ICC modiﬁcation
post transplantation is likely through SCF signalling from
transplanted neurons.
One of the challenges for cell replenishment therapies is scaling
up for potential human application. It remains possible that
signiﬁcant cell numbers will be required to facilitate functional
outcomes in human patients. A recent study has demonstrated
derivation of enteric neural crest from human pluripotent stem
cells and potential rescue of a Hirschsprung phenotype48.
As opposed to our study, this investigation transplanted up to 4
million cells to Ednrbs l/s l (SSL/LEJ) colon. While trans-
plantation led to survival of mice, no mechanism was presented
of the graft-mediated host rescue. The ﬁndings of our study suggest
that in addition to engraftment of neural crest cells, non-cell-
autonomous modiﬁcation of the neuromuscular apparatus may be
responsible for this rescue. Our study thus highlights the potential
to apply a limited number of cells, to a particular area, which
subsequently could impact on function throughout the organ and
have signiﬁcant clinical beneﬁts. In addition, we demonstrate the
potential for collecting postnatal tissue for use in transplantation
studies and the ability of cells from this source to restore function.
This caveat has signiﬁcant therapeutic beneﬁts as ENSC could be
collected autologously or from matched donors to limit the
potential for immunological rejection. Moreover, previous long-
term safety studies using identical postnatal ENSC have
demonstrated long-term survival of ENSC-derived cells restricted
only to the region of transplantation16, which may provide a
substantial beneﬁt over the potential therapeutic application of cells
derived from pluripotent sources.
We conclude that this study provides the ﬁrst evidence that
ENSC can rescue GI motility within a neuropathic model and
may provide the basis for development of targeted cellular
therapies for enteric neuropathies.
Methods
Animals. Male and female Wnt1cre/þ ;R26RYFP/YFP mice, in which neural crest
cells express YFP, were used as donors to obtain YFPþ ENSC. Heterozygote nNOS
(B6.129S4-Nos1tm1Plh/J) mice were obtained from The Jackson Laboratory
(Bar Harbor, MN, USA). Male and female homozygote nNOS knockout
(nNOS / ) mice were bred and maintained for use as recipients. Four–5-week-
old C57BL/6J mice were obtained from The Jackson Laboratory (Bar Harbor,
MN, USA) and killed as age-matched controls at 6 weeks. Animals used for these
studies were maintained, and the experiments performed, in accordance with the
UK Animals (Scientiﬁc Procedures) Act 1986 and approved by the University
College London Biological Services Ethical Review Process. Animal husbandry at
UCL Biological Services was in accordance with the UK Home Ofﬁce Certiﬁcate of
Designation.
Cell isolation and enrichment. The entire small intestine and colon was
obtained from early postnatal (P2–P7) Wnt1cre/þ ;R26RYFP/YFP mice after cervical
dislocation, and removed to sterile PBS for further dissection. Jejunum, ileum and
colon muscle strips were obtained following removal of the mucosa via ﬁne
dissection. Intestinal cells were dissociated and YFPþ cells isolated using
ﬂuorescence-activated cell sorting with a MoFloXDP cell sorter (Beckman Coulter,
UK). YFP positive (YFPþ ) cells were selected using a 530/40 ﬁlter set. Gating
parameters were set using cells from wild-type gut and applied to increase
speciﬁcity of selection of YFPþ cells.
Neurosphere culture. YFPþ cells were plated on ﬁbronectin-coated six-well
dishes in ‘neurosphere medium’ (NSM; DMEM F12 supplemented with B27
(Invitrogen, UK), N2 (Invitrogen, UK), 20 ngml 1 EGF (Peprotech, UK),
20 ngml 1 FGF (Peprotech, UK) and Primocin antibiotic (InvivoGen, UK)
and maintained in culture for up to 4 weeks. Typically such cultures from early
postnatal (P2–P7) intestine formed ‘neurospheres’ at B1 week in culture.
In vivo ENSC transplantation. YFP-expressing neurospheres derived from
Wnt1cre/þ ;R26RYFP/YFP mice were transplanted into the distal colon of P14–P17
nNOS / , via laparotomy under isoﬂurane anaesthetic. Brieﬂy, the distal colon
was exposed and a small pocket was created in the tunica muscularis with the bevel
of a 30G needle. A neurosphere, containing B2 104 YFPþ cells, was subse-
quently transplanted to this site by mouth pipette using a pulled glass micropipette.
Each transplanted tissue typically received three neurospheres (B6 104 YFPþ
cells in total). Transplanted nNOS / mice were typically maintained for 4 weeks
post transplantation before killing and removal of the colon for analysis. ‘Sham’
operations were performed as controls in which the intestine was manipulated in
an identical fashion without the addition of YFPþ cells.
RT–PCR. Total RNA was isolated from C57BL/6J, nNOS / or transplanted
nNOS / brain, stomach and colon using TRIzol reagent (Life Technologies Ltd,
Paisley, UK) and treated with DNase I (Qiagen, Manchester, UK). First-strand
cDNA was ampliﬁed from 1 mg RNA using SuperScript VILO cDNA Synthesis Kit
(Life Technologies Ltd, Paisley, UK). PCR was performed using region-speciﬁc
primers for nNOS (Supplementary Table 1) using HotStarTaq DNA Polymerase
(Qiagen, Manchester, UK). PCR reactions were performed in a PTC-200 Peltier
Thermal Cycler (MJ Research Inc. Waltham, MA, USA). The ampliﬁcation proﬁle
was 95 C for 3min, 35 cycles of 94 C for 30 s, 60 C for 60 s and 72 C for 30 s,
followed by a ﬁnal step of 72 C for 2min. RT–PCR ampliﬁcation fragments were
analysed on a 2% agarose gel alongside a Hyperladder 25 bp marker (Bioline,
London, UK).
qRT–PCR. Total RNA was isolated from three pooled neurospheres at the time of
surgery using an RNeasy Micro Kit (Qiagen, Hilden, Germany), according to the
manufacturer’s instructions. First-strand cDNA was ampliﬁed from 100 ng RNA
using SuperScript VILO cDNA Synthesis Kit (Life Technologies Ltd, Paisley, UK).
RT quantitative PCR was performed with an ABI Prism 7500 sequence
detection system (Applied Biosystems) using the Quantitect SYBR Green PCR kit
(Qiagen, Hilden, Germany) according to the manufacturer’s instructions.
qRT–PCR was performed in triplicate using region-speciﬁc primers for GAPDH,
TuJ1, SOX10 and S100 (Supplementary Table 1). Gene expression data were
expressed as a proportion of GAPDH housekeeping gene, as a reference, using
a 1/DCt calculation.
Immunohistochemistry. Neurosphere immunohistochemistry was performed
following paraformaldehyde ﬁxation (4% w/v in 0.1mol l 1 PBS for 45min at
22 C). After ﬁxation, neurospheres were washed for 1 h in PBS (0.01mol l 1,
pH 7.2 at 4 C). Neurospheres were blocked for 1 h (0.1mol l 1 PBS containing
1% Triton X-100, 1% BSA and 0.15% glycine) at 22 C. The primary antibodies
used in the study are listed in Supplementary Table 2. Intact neurospheres were
incubated in primary antibody (diluted in 0.1mol l 1 PBS containing 1% Triton
X-100, 1% BSA and 0.15% glycine) overnight at 4 C and immunoreactivity was
detected using secondary antibodies (1:500 in 0.1mol l 1 PBS, 1 h at room
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temperature, Supplementary Table 3). Before mounting, neurospheres were washed
thoroughly in PBS (0.1mol l 1 PBS for 1 h at 22 C).
Whole-mount immunohistochemistry was performed on transplanted colonic
segments after excision and removal of the mucosa by sharp dissection. Tissues
were ﬁxed in paraformaldehyde (4% w/v in 0.1mol l 1 PBS for 45min at 22 C).
After ﬁxation, tissues were washed for 24 h in PBS (0.01mol l 1, pH 7.2 at 4 C).
Tissues were blocked for 1 h (0.1mol l 1 PBS containing 1% Triton X-100, 10%
sheep serum). Tissues were incubated in primary antibody (diluted in 0.1mol l 1
PBS containing 1% Triton X-100, 10% sheep serum, Supplementary Table 2) for
48 h at 4 C and immunoreactivity was detected using the secondary antibodies
listed in Supplementary Table 3 (1:500 in 0.1mol l 1 PBS, 1 h at room
temperature). Before mounting, tissues were washed thoroughly in PBS
(0.1mol l 1 PBS for 2 h at 22 C). Control tissues were prepared by omitting
primary or secondary antibodies. Tissues and neurospheres were examined using a
LSM710 meta confocal microscope (Zeiss, Germany). Confocal micrographs
were digital composites of the Z-series of scans (0.5 mm optical sections). For
cell-counting experiments, ﬁve Z-series scans (21 1 mm optical sections including
longitudinal muscle, myenteric plexus and circular muscle layers) were obtained in
each region per animal. Z-series ﬁles were blinded before counting. Individual cells
were identiﬁed with DAPI co-labelling and cell counts performed across each
individual z-scan using the cell counter plugin (FIJI). Each Z-series count
(21 sections) was summed and average cell number was calculated as a mean of ﬁve
Z-series scans per region in each animal. For confocal montage experiments, tissues
were examined using a LSM880 multiphoton microscope (Zeiss, Germany).
Confocal micrographs of whole mounts were digital composites of the Z-series of
scans stitched using Zen software (Zeiss, Germany). Final images were constructed
using FIJI software49 after applying a post-acquisition Gaussian ﬁlter with a s of 2.
For NADPH diaphorase staining, colonic tissues were prepared, ﬁxed and
washed as above. NADPH diaphorase activity was detected by incubating tissues
in 0.1mol l 1 PBS containing 0.05% Triton X-100, 1mgml 1 b-NADPH
(Sigma, UK) and 0.5mgml 1 nitrobluetetrazolium (Sigma, UK) for 20min at
37 C. After staining, the tissues were washed thoroughly in PBS (0.1mol l 1)
before mounting.
Haemeotoxylin and eosin colonic cryostat sections (20 mm) were obtained from
frozen gelatin-embedded samples using a Leica CM1900 UV Cryostat (Leica
Microsystems, UK) and processed for haemeotoxylin and eosin. Brieﬂy, frozen
colonic sections were post ﬁxed in PFA (4% w/v in 0.1mol l 1 PBS for 45min at
22 C), washed thoroughly and haemeotoxylin solution (Harris modiﬁed; Sigma,
UK) applied for 7min at 22 C. After washing, slides were immersed in acid alcohol
(1% HCl in 70% EtOH) for 10 s and washed before application of 1% eosin Y
(Fisher Scientiﬁc, UK) for 5min at 22 C. Samples were subsequently washed,
dehydrated and cleared in Histoclear (2 1min at 4 C; National Diagnostics, UK)
before mounting.
In vivo transit analysis. To test GI transit, either 100 ml Gastrosense 750
(Perkin Elmer, USA) or 100 ml Brilliant Blue FCT (E122) solution (Langdales, UK)
was administered to the stomach via gavage at 6 weeks (4 weeks post transplan-
tation). Total GI transit time was calculated from time of administration to the ﬁrst
visualization of dye in the stool. Stool output in 1 h was calculated as: total number
of stool in 1 h stool weight. To assess stomach emptying and partial transit time,
Gastrosense 750 ﬂuorescence was imaged using an IVIS Lumina III In Vivo
Imaging System (Perkin Elmer, USA). At 30min, in vivo images were obtained and
percentage stomach emptying calculated as: 1 Stomach fluorescenceTotal flourescence
  100:
To assess partial intestinal transit, the GI tract (stomach to terminal colon) was
removed 90min after Gastrosense 750 administration. Flourescence images were
obtained of the GI tract and percentage intestinal transit calculated as:
Dye transit distance
Total intestinal length100:
Contractility. Longitudinal colonic muscle strips were isolated and the mucosa
removed by sharp dissection in oxygenated Krebs solution. Longitudinal muscle
strips were mounted in tissue baths (10ml, SI-MB4; World Precision Instruments
Ltd, UK) connected via suture to force transducers (SI-KG20, World Precision
Instruments Ltd, UK) under an initial tension of 0.5 g. Tissues were maintained
at 37 C with perfusion of oxygenated Krebs solution. Following a 60min
equilibration period, activity was recorded using a Lab-Trax-4 data acquisition
system (World Precision Instruments Ltd, UK) in the absence and presence of
non-adrenergic non-cholinergic conditions (Atropine; 1 mM, Phentolamine
hydrochloride; 1 mM, Propranolol hydrochloride; 1 mM). Nerves were stimulated
for 30 s (5Hz; 40 V; 0.3ms pulse duration) via EFS via platinum electrode loops
placed at each end of the muscle strip using a MultiStim System (D330, World
Precision Instruments Ltd, UK). Addition of L-NAME (100 mM) or TTX (1 mM) to
the bath solution was used to assess the nitrergic and neurally mediated responses,
respectively. EFS gave rise to neural responses that were sensitive to TTX.
Data were collected, stored and analysed by computer using a data acquisition
programme (Labscribe 2-1, World Precision Instruments Ltd, UK).
Statistical analysis. Data are expressed as mean±s.e.m. Differences in the data
were evaluated between nNOS / control, sham-operated and transplanted
groups using one-way ANOVA and subsequent intergroup differences were
determined by unpaired Student’s t-test. P values o0.05 were taken as statistically
signiﬁcant. The ‘n values’ reported refer to the number of mice or colonic segments
used for each protocol. Each muscle was taken from a separate animal.
Data availability. The authors declare that all data supporting the ﬁndings of this
study are available within the article and its Supplementary Information ﬁles or
from the corresponding author on reasonable request.
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